Sushil Patel, Director at Revolution Medicines, Inc. (RVMD), sold 2,155 shares at $37.00 ($80K) on 2024-04-10, disclosed to the SEC on 2024-04-12.
Scheduled sale ($80k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| REPL | SELL | 2026-05-20 | $190K | — | Filing → |
| REPL | SELL | 2025-12-04 | $223K | — | Filing → |
| REPL | SELL | 2025-05-22 | $405K | — | Filing → |